Business Wire

Neustar Security Services Spins Out with Focused Investment to Foster Accelerated Growth

1.12.2021 17:46:00 EET | Business Wire | Press release

Share

Neustar Security Services, LLC (“Neustar Security Services”), a leading global provider of cloud-oriented security services that enable global business to thrive online, has become the newest portfolio company of Golden Gate Capital and GIC following the completed sale of Neustar Inc.’s (“Neustar”) Marketing, Risk and Communications solutions businesses to TransUnion.

The spin out marks Neustar Security Services’ entry into its next phase of growth with the focused backing of its investors and strong continuity of leadership. Brian McCann, who has served as President of Neustar’s Security business since 2019, has been appointed CEO of Neustar Security Services and will lead the company’s more than 250 employees. Neustar President and CEO, Charlie Gottdiener, will serve as a Director on the Neustar Security Services Board of Directors. In addition to McCann, the Company’s senior leadership team will include Anthony Chadd, Senior Vice President and Chief Revenue Officer; Carlos Morales, Senior Vice President, Solutions; Mark Robinson, Senior Vice President, Technology; and James Willett, Senior Vice President, Operations.

The move follows four years of strategic investment that has enabled Neustar Security Services to become a leading cloud-oriented security services provider, resulting in increased resilience against disruptions and cyberattacks. With support from Golden Gate Capital and GIC, Neustar Security Services re-architected its platforms and significantly expanded network capacity and performance for DNS and DDoS services, adding a host of new solutions and features across its Ultra Secure product portfolio and services suite. It also launched seamlessly integrated offerings for cloud WAF and bot management to address application security, and new threat feed data services to increase visibility to threat intelligence platforms. Together, these investments have improved Neustar Security Services’ performance and security for current and future Global 5000 enterprise customers.

“Today is a very exciting day, and the dawn of a new era for Neustar Security Services,” said Mr. McCann. “Through the successful execution of its multi-year transformation strategy, Neustar Security Services has established a highly scalable, fully cloud-delivered platform with capacity to support multiple mission-critical security services with the highest service and performance in the industry. Our core DNS, DDoS and application security services provide the industry’s best combination of performance, availability, and security for any enterprise. The Neustar Security Services team will remain focused on delivering reliability and demonstrating our commitment to always doing more for our customers while developing additional industry-leading services and further expanding our global reach.”

Rishi Chandna, Managing Director at Golden Gate Capital, said, “Sophisticated cyberattacks are constantly evolving, and we are consistently impressed by Neustar Security Services’ ability to help their customers combat the next generation of challenges and threats. Neustar Security Services has an impressive platform, vision and strategy to drive significant value and growth, and we are excited to partner with Brian and his talented team to support the company in this next chapter.”

“Golden Gate Capital and GIC are committed to implementing a targeted investment strategy that will support Neustar Security Services’ ability to continuously develop and enhance its industry-leading technology and services,” said Mr. Gottdiener. “We believe that the company’s intensified focus as a stand-alone entity will enable it to act with greater agility and dynamism as it addresses the massive and growing market need for cloud-based security solutions.”

In addition to offering newly integrated services in the Ultra Secure portfolio, the company will continue to accelerate the expansion of its sales, marketing and service capabilities while looking to capitalise on its recently revamped and relaunched channel offering, the Ultra Secure Partner Program, to better serve its Global 5000 customer base.

Neustar Security Services will continue to support its global base of enterprise customers from its current headquarters in Sterling, Virginia.

About Neustar Security Services

The world’s top brands depend on Neustar Security Services to safeguard their digital infrastructure and online presence. Neustar Security Services offers a suite of cloud-delivered services that are secure, reliable, and available to enable global businesses to thrive online. The company’s Ultra Secure suite of solutions protects organisations’ networks and applications against risks and downtime, ensuring that businesses and their customers enjoy exceptional interactions all day, every day. Delivering the industry’s best performance service, Neustar Security Services’ mission-critical security portfolio provides best-in-class DNS, application and network security including DDoS, WAF and Bot management, and threat feed services to its Global 5000 customers and beyond. For more information, visit https://www.home.neustar/security-solutions.

About Golden Gate Capital

Golden Gate Capital is a San Francisco-based private equity investment firm with over $19 billion in cumulative committed capital. The principals of Golden Gate Capital have a long and successful history of investing across a wide range of industries and transaction types, including going-privates, corporate divestitures, and recapitalisations, as well as debt and public equity investments. Notable software and technology-enabled services investments sponsored by Golden Gate Capital include Infor, BMC Software, LiveVox, Vector Solutions, Ex Libris, 2020 Technologies and Ensemble Health Partners. For more information, visit www.goldengatecap.com.

About GIC

GIC is a leading global investment firm established in 1981 to secure Singapore’s financial future. As the manager of Singapore’s foreign reserves, we take a long-term, disciplined approach to investing and are uniquely positioned across a wide range of asset classes and active strategies globally. These include equities, fixed income, real estate, private equity, venture capital and infrastructure. Our long-term approach, multi-asset capabilities and global connectivity enable us to be an investor of choice. We seek to add meaningful value to our investments. Headquartered in Singapore, we have a global talent force of over 1,800 people in 10 key financial cities and have investments in over 40 countries.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Neustar Security Services
Miranda Joseph
miranda.joseph@team.neustar

Golden Gate Capital
David Isaacs / Anne Nisperos Hew
GoldenGate-SVC@sardverb.com

GIC
Katy Conrad
katyconrad@gic.com.sg

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release

Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release

Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye